Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.
|
AIDS
|
2014
|
2.67
|
2
|
Response to combination antiretroviral therapy: variation by age.
|
AIDS
|
2008
|
2.28
|
3
|
Risk of triple-class virological failure in children with HIV: a retrospective cohort study.
|
Lancet
|
2011
|
1.90
|
4
|
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women.
|
Clin Infect Dis
|
2007
|
1.88
|
5
|
Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment.
|
Curr HIV Res
|
2007
|
1.85
|
6
|
CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
|
J Infect Dis
|
2006
|
1.46
|
7
|
Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?
|
J Acquir Immune Defic Syndr
|
2005
|
1.32
|
8
|
Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women.
|
J Reprod Immunol
|
2006
|
1.16
|
9
|
Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIV-uninfected mothers in rural South Africa.
|
Antivir Ther
|
2012
|
1.13
|
10
|
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years.
|
Arch Intern Med
|
2010
|
1.12
|
11
|
Reproductive experience of HIV-infected women living in Europe.
|
Hum Reprod
|
2008
|
1.12
|
12
|
Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa.
|
Hum Reprod
|
2012
|
1.12
|
13
|
Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery.
|
AIDS
|
2004
|
1.10
|
14
|
Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
|
AIDS
|
2005
|
1.08
|
15
|
Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date.
|
Eur J Public Health
|
2006
|
1.08
|
16
|
Increasing likelihood of further live births in HIV-infected women in recent years.
|
BJOG
|
2005
|
1.05
|
17
|
Pregnancy and HIV infection: A european consensus on management.
|
AIDS
|
2002
|
1.04
|
18
|
Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda.
|
Ann Trop Paediatr
|
2006
|
1.03
|
19
|
Tuberculosis and HIV co-infection in children.
|
BMC Infect Dis
|
2014
|
1.00
|
20
|
Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe.
|
Eur J Epidemiol
|
2007
|
0.99
|
21
|
Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network.
|
J Pediatr Gastroenterol Nutr
|
2009
|
0.97
|
22
|
Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990-2009.
|
J Acquir Immune Defic Syndr
|
2012
|
0.96
|
23
|
Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women?
|
J Acquir Immune Defic Syndr
|
2005
|
0.96
|
24
|
National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?
|
Eur J Public Health
|
2013
|
0.95
|
25
|
Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.
|
J Acquir Immune Defic Syndr
|
2011
|
0.94
|
26
|
Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.
|
J Acquir Immune Defic Syndr
|
2012
|
0.94
|
27
|
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe.
|
Antivir Ther
|
2011
|
0.92
|
28
|
Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.
|
AIDS
|
2013
|
0.92
|
29
|
Cell-free (RNA) and cell-associated (DNA) HIV-1 and postnatal transmission through breastfeeding.
|
PLoS One
|
2012
|
0.91
|
30
|
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.
|
AIDS
|
2013
|
0.90
|
31
|
Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
|
BMC Infect Dis
|
2007
|
0.89
|
32
|
Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
|
N Engl J Med
|
2003
|
0.89
|
33
|
Pregnancies in young women with vertically acquired HIV infection in Europe.
|
AIDS
|
2007
|
0.89
|
34
|
Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine.
|
Bull World Health Organ
|
2013
|
0.89
|
35
|
Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine.
|
BMC Pediatr
|
2010
|
0.88
|
36
|
Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine.
|
PLoS One
|
2012
|
0.88
|
37
|
Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.
|
Clin Infect Dis
|
2011
|
0.87
|
38
|
Mother-to-child transmission risk is increased among HIV-infected pregnant women in Ukraine with serological test results positive for syphilis.
|
Clin Infect Dis
|
2008
|
0.87
|
39
|
Post-licensing safety of fosamprenavir in HIV-infected children in Europe.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.86
|
40
|
Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe.
|
Clin Infect Dis
|
2009
|
0.86
|
41
|
Vertically acquired paediatric coinfection with HIV and hepatitis C virus.
|
Lancet Infect Dis
|
2006
|
0.85
|
42
|
Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?
|
AIDS
|
2014
|
0.84
|
43
|
Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women.
|
BMC Med Res Methodol
|
2012
|
0.84
|
44
|
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.
|
J Acquir Immune Defic Syndr
|
2013
|
0.84
|
45
|
Antiretroviral therapy and mother-to-child transmission of HIV-1.
|
Expert Rev Anti Infect Ther
|
2004
|
0.84
|
46
|
Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine.
|
BMC Public Health
|
2014
|
0.83
|
47
|
Factors associated with abandonment of infants born to HIV-positive women: results from a Ukrainian birth cohort.
|
AIDS Care
|
2010
|
0.83
|
48
|
Prenatal diagnosis in human immunodeficiency virus-infected women: a new screening program for chromosomal anomalies.
|
Am J Obstet Gynecol
|
2006
|
0.82
|
49
|
Current guidelines on management of HIV-infected pregnant women: impact on mode of delivery.
|
Eur J Obstet Gynecol Reprod Biol
|
2008
|
0.82
|
50
|
Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception.
|
AIDS
|
2011
|
0.82
|
51
|
Levels and patterns of HIV RNA viral load in untreated pregnant women.
|
Int J Infect Dis
|
2008
|
0.81
|
52
|
The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy.
|
AIDS
|
2015
|
0.81
|
53
|
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals.
|
BMC Pregnancy Childbirth
|
2013
|
0.78
|
54
|
The new face of the pediatric HIV epidemic in Western countries: demographic characteristics, morbidity and mortality of the pediatric HIV-infected population.
|
Pediatr Infect Dis J
|
2015
|
0.77
|
55
|
Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
|
Antivir Ther
|
2012
|
0.77
|
56
|
Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
|
Curr Opin HIV AIDS
|
2016
|
0.77
|
57
|
Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe.
|
AIDS
|
2013
|
0.77
|
58
|
European participation in an international perinatal trial.
|
Med Wieku Rozwoj
|
2004
|
0.77
|
59
|
Policies and practices for the clinical management of HIV/HCV coinfected children in Europe: an epidemiological survey.
|
Eur J Pediatr
|
2008
|
0.76
|
60
|
Breastfeeding and transmission of viruses other than HIV-1.
|
Adv Exp Med Biol
|
2012
|
0.76
|
61
|
Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.
|
AIDS
|
2015
|
0.76
|
62
|
A new piece in the puzzle of antiretroviral therapy in pregnancy and preterm delivery risk.
|
Clin Infect Dis
|
2012
|
0.75
|
63
|
Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
64
|
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model.
|
Epidemiology
|
2016
|
0.75
|
65
|
Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
66
|
Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
|
AIDS
|
2007
|
0.75
|
67
|
Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women.
|
BMC Infect Dis
|
2014
|
0.75
|
68
|
HIV and HCV progression in parenterally coinfected children.
|
Curr HIV Res
|
2009
|
0.75
|
69
|
The Challenge of Treating Children with Hepatitis C Virus Infection.
|
J Pediatr Gastroenterol Nutr
|
2017
|
0.75
|
70
|
Pregnancy incidence and outcomes in women with perinatal HIV infection.
|
AIDS
|
2017
|
0.75
|
71
|
Syphilis, hepatitis C and HIV in Eastern Europe.
|
Curr Opin Infect Dis
|
2016
|
0.75
|